CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

You are here

Products

back to search results

CD235a/Glycophorin A [EPR8200]

Product group: Primary
Monoclonal/ Polyclonal: Monoclonal
Clone: EP213 equivalent to EPR8200
Host: Rabbit
Isotype: IgG
Application: Immunohistochemistry (IHC)
Application notes: 50-200
Conjugation Type: Unconjugated
Reactivity: Human
General notes: Localization: membrane.
Buffer: citrate pH6.0
UNSPSC code: 12352203

Glycophorin A, also known as CD235a, is the major intrinsic membrane protein of the erythrocyte. The N-terminal glycosylated segment, which lies outside of the erythrocyte membrane, has MN blood group receptors. It is important for the function of SLC4A1 and required for the high activity of SLC4A1. Glycophorin A may be involved in the translocation of SLC4A1 to the plasma membrane. It is a receptor for the influenza virus and Plasmodium falciparum erythrocyte-binding antigen 175 (EBA-175); binding of EBA-175 is dependent on sialic acid residues of the O-linked glycans. Glycophorin A is exclusively expressed on erythroid cells and their precursors. It is a useful marker for identification of erythroid differentiation in hematopoietic malignancies. (Shipping Cost: €200.00)

CD235a/Glycophorin A [EPR8200]

Glycophorin A, also known as CD235a, is the major intrinsic membrane protein of the erythrocyte. The N-terminal glycosylated segment, which lies outside of the erythrocyte membrane, has MN blood group receptors. It is important for the function of SLC4A1 and required for the high activity of SLC4A1. Glycophorin A may be involved in the translocation of SLC4A1 to the plasma membrane. It is a receptor for the influenza virus and Plasmodium falciparum erythrocyte-binding antigen 175 (EBA-175); binding of EBA-175 is dependent on sialic acid residues of the O-linked glycans. Glycophorin A is exclusively expressed on erythroid cells and their precursors. It is a useful marker for identification of erythroid differentiation in hematopoietic malignancies.